Eris Lifesciences Limited has informed the Exchange regarding a press release dated March 14, 2024, titled "Eris Lifesciences acquires the commercial rights to Biocon Biologics India Branded Formulations business; both organisations enter into a long- term collaboration to expand patient access in India.".